BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1
2589 results:

  • 1. The application of a single-hand-operated hepatic pedicle clamping clamp in laparoscopic hepatectomy.
    Shen Z; Jiang B; Chu H; Wang G; Fang X; Chen Z; Yang Y; Wang J; Wang X
    Langenbecks Arch Surg; 2024 Apr; 409(1):146. PubMed ID: 38691172
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Strategies to Perform Emergency Laparoscopic Partial liver Resection for Ruptured Hepatocellular Carcinoma.
    Tsunematsu M; Onda S; Shirai Y; Abe K; Horiuchi T; Haruki K; Furukawa K; Okui N; Taniai T; Ikegami T
    Anticancer Res; 2024 May; 44(5):2171-2176. PubMed ID: 38677754
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.
    Zeng D; Yu C; Chen S; Zou L; Chen J; Xu L
    World J Surg Oncol; 2024 Apr; 22(1):93. PubMed ID: 38605359
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis.
    Zhang H; Liu J
    Sci Rep; 2024 Apr; 14(1):8502. PubMed ID: 38605235
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Single extract of Forsythia Suspense versus the prepared drug in pieces: comparison of their anti-inflammatory, antitumor and antibacterial effects in zebrafish].
    Guo X; Guo Z; Sun D; Zou L; Ou J; Yu L; Lu Z; Cao H; Liu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):594-604. PubMed ID: 38597452
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    Bray F; Laversanne M; Sung H; Ferlay J; Siegel RL; Soerjomataram I; Jemal A
    CA Cancer J Clin; 2024; 74(3):229-263. PubMed ID: 38572751
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Robot-assisted versus laparoscopic pancreatoduodenectomy: a pan-European multicenter propensity-matched study.
    Emmen AMLH; Zwart MJW; Khatkov IE; Boggi U; Groot Koerkamp B; Busch OR; Saint-Marc O; Dokmak S; Molenaar IQ; D'Hondt M; Ramera M; Keck T; Ferrari G; Luyer MDP; Moraldi L; Ielpo B; Wittel U; Souche FR; Hackert T; Lips D; Can MF; Bosscha K; Fara R; Festen S; van Dieren S; Coratti A; De Hingh I; Mazzola M; Wellner U; De Meyere C; van Santvoort HC; Aussilhou B; Ibenkhayat A; de Wilde RF; Kauffmann EF; Tyutyunnik P; Besselink MG; Abu Hilal M;
    Surgery; 2024 Jun; 175(6):1587-1594. PubMed ID: 38570225
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Challenges in Diagnosis and Treatment of Male Hypogonadism.
    Purnamasari D
    Acta Med Indones; 2024 Jan; 56(1):1-2. PubMed ID: 38561883
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.
    Yarchoan M; Powderly JD; Bastos BR; Karasic TB; Crysler OV; Munster PN; McKean MA; Emens LA; Saenger YM; Ged Y; Stagg R; Smith S; Whiting CC; Moon A; Prasit P; Jenkins Y; Standifer N; Dubensky TW; Whiting SH; Ulahannan SV
    Cancer Res Commun; 2024 Apr; 4(4):1100-1110. PubMed ID: 38551394
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells.
    Chaisupasakul P; Pekthong D; Wangteeraprasert A; Kaewkong W; Somran J; Kaewpaeng N; Parhira S; Srisawang P
    PLoS One; 2024; 19(3):e0300051. PubMed ID: 38527038
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Salivary gland adenoid cystic carcinoma in the U.S population: Importance of grade, site of metastases, and adjuvant radiation for survival.
    Ullah A; Ahmed A; Lee KT; Yasinzai AQK; Lewis JS
    Am J Otolaryngol; 2024; 45(3):104266. PubMed ID: 38522261
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
    Gordan JD; Kennedy EB; Abou-Alfa GK; Beal E; Finn RS; Gade TP; Goff L; Gupta S; Guy J; Hoang HT; Iyer R; Jaiyesimi I; Jhawer M; Karippot A; Kaseb AO; Kelley RK; Kortmansky J; Leaf A; Remak WM; Sohal DPS; Taddei TH; Wilson Woods A; Yarchoan M; Rose MG
    J Clin Oncol; 2024 May; 42(15):1830-1850. PubMed ID: 38502889
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [cancer incidence and mortality in China, 2022].
    Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
    [No Abstract]    [Full Text] [Related]  

  • 14. Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with tyrosine kinase inhibitors (TKIs) in patients with unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis.
    Ji J; Zhang Z; Hou Z; Qiu G; Mi S; Jin Z; Huang J
    Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102313. PubMed ID: 38453011
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Optimizing lifestyle profiles is potential for preventing nonalcoholic fatty liver disease and enhancing its survival.
    Tu B; Li W; Xiao H; Xu X; Zhang Y
    Sci Rep; 2024 Mar; 14(1):5516. PubMed ID: 38448563
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Chemoembolization as first-line treatment for hepatocellular carcinoma invading segmental portal vein with tumour burden limited to a monosegmental level.
    Hwang H; Kim JH; Ko E; Kim JY; Ko HK; Gwon DI; Shin JH; Kim GH; Chu HH
    Br J Radiol; 2024 May; 97(1157):1038-1043. PubMed ID: 38445658
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
    Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
    Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk factors associated with hepatitis D virus infection and preventive strategies in Mongolia.
    Su CW; Ochirkhuree B; Namdag B; Badamnachin B; Ganbold S; Gidaagaya S; Ganbold A; Yang SS; Duger D; Wu JC
    J Chin Med Assoc; 2024 May; 87(5):480-487. PubMed ID: 38417133
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
    Yau T; Kaseb A; Cheng AL; Qin S; Zhu AX; Chan SL; Melkadze T; Sukeepaisarnjaroen W; Breder V; Verset G; Gane E; Borbath I; Rangel JDG; Ryoo BY; Makharadze T; Merle P; Benzaghou F; Milwee S; Wang Z; Curran D; Kelley RK; Rimassa L
    Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):310-322. PubMed ID: 38364832
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA-II), serum a-fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non-diagnostic serum a-fetoprotein levels.
    Syriha A; Pantzios S; Mandilara D; Galanis P; Stathopoulou I; Barla G; Elefsiniotis I
    Cancer Med; 2024 Feb; 13(3):e6825. PubMed ID: 38361401
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 130.